Aqr Capital Management LLC Palatin Technologies Inc Transaction History

Aqr Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 17, 2020	SELL	$0.41 - $0.73 $84,535 - $150,513	-206,183 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$0.36 - $0.79 $191,288 - $419,771	-531,356 Reduced 72.04%	206,183 $87,000
Q4 2019 Feb 14, 2020	BUY	$0.75 - $0.89 $553,154 - $656,409	737,539 New	737,539 $577,000
Q2 2019 Aug 14, 2019	SELL	$0.98 - $1.64 $178,551 - $298,799	-182,195 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$0.67 - $1.01 $524,289 - $790,347	-782,522 Reduced 81.11%	182,195 $179,000
Q4 2018 Feb 14, 2019	BUY	$0.63 - $1.0 $366,009 - $580,968	580,968 Added 151.39%	964,717 $683,000
Q3 2018 Nov 15, 2018	BUY	$0.88 - $1.1 $321,789 - $402,237	365,670 Added 2022.62%	383,749 $383,000
Q2 2018 Aug 14, 2018	BUY	$0.91 - $1.45 $16,451 - $26,214	18,079 New	18,079 $18,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $10.5M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.